- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 1008510-37-9] Razuprotafib
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-109041 |
| Brand: | MCE |
| CAS: | 1008510-37-9 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 586.70 |
| Molecular Formula | C26H26N4O6S3 |
| SMILES | O=C([C@@H](NC(OC)=O)CC1=CC=CC=C1)N[C@H](C2=CSC(C3=CC=CS3)=N2)CC4=CC=C(NS(=O)(O)=O)C=C4 |
1 Publications Citing Use of MCE
Summary
Razuprotafib (AKB-9778) is a potent and selective inhibitor of the catalytic activity of VE-PTP (vascular endothelial protein tyrosine phosphatase) with an IC 50 of 17 pM. Razuprotafib promotes TIE2 activation, enhances ANG1-induced TIE2 activation, and stimulates phosphorylation of signaling molecules in the TIE2 pathway, including AKT , eNOS , and ERK . Razuprotafib inhibits the structurally related phosphatase PTP1B with an IC 50 of 780 nM. Razuprotafib shows excellent selectivity for VE-PTP versus a variety of phosphatases, with the exception of HPTPη (IC 50 =36 pM) and HPTPγ (100 pM) [1] .
In Vitro
Razuprotafib (AKB-9778) promotes TIE2 phosphorylation and activation of downstream signaling in HUVECs and enhances angiopoietin-induced TIE2 phosphorylation [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Razuprotafib (20 mg/kg; s.c.) promotes phosphorylation of TIE2 in retinal endothelial cells in vivo
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT03197870 | Aerpio Therapeutics |
Nonproliferative Diabetic Retinopathy
|
June 9, 2017 | Phase 2 |
| NCT02858271 | Aerpio Therapeutics |
Healthy
|
July 2016 | Phase 1 |
| NCT02050828 | Aerpio Therapeutics |
Diabetic Macular Edema (DME)
|
January 2014 | Phase 2 |
| NCT01702441 | Aerpio Therapeutics |
Diabetic Macular Edema (DME)
|
September 2012 | Phase 1|Phase 2 |
| NCT04511650 | Aerpio Therapeutics|Medical Technology Enterprise Consortium (MTEC) |
COVID-19|Acute Respiratory Distress Syndrome
|
October 21, 2020 | Phase 2 |
| NCT04284514 | Aerpio Therapeutics |
Ocular Hypertension|Primary Open Angle Glaucoma
|
May 2, 2019 | Phase 1 |
| NCT02387788 | Aerpio Therapeutics |
Retinal Vein Occlusion
|
January 2015 | Phase 2 |
| NCT04405245 | Aerpio Therapeutics |
Ocular Hypertension|Primary Open Angle Glaucoma
|
June 6, 2020 | Phase 2 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 100 mg/mL ( 170.44 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.7044 mL | 8.5222 mL | 17.0445 mL |
| 5 mM | 0.3409 mL | 1.7044 mL | 3.4089 mL |
| 10 mM | 0.1704 mL | 0.8522 mL | 1.7044 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.